{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:43:34Z","timestamp":1775123014828,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,13]]},"DOI":"10.7759\/cureus.31437","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T14:38:40Z","timestamp":1668350320000},"source":"Crossref","is-referenced-by-count":16,"title":["The Evolution of Hypertension Guidelines Over the Last 20+ Years: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Endurance O","family":"Evbayekha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okelue E","family":"Okobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobechukwu","family":"Okobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeka C","family":"Ibeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane N","family":"Nwafor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oyintoun-emi","family":"Ozobokeme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adedoyin","family":"Olawoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihuoma A","family":"Ngoladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen G","family":"Boms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faridah A","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babatunde  O","family":"Oyelade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C","family":"Okoroafor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian N","family":"Chukwuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesena B","family":"Alex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evidence E","family":"Ohikhuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2223","article-title":"Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement","volume":"163","author":"Siu AL","year":"2015","unstructured":"Siu AL. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015, 163:778-86. 10.7326\/M15-2223","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James PA","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al.. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014, 311:507-20. 10.1001\/jama.2013.284427","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US preventive services task force recommendation statement","volume":"325","author":"Krist AH","year":"2021","unstructured":"Krist AH, Davidson KW, Mangione CM, et al.. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021, 325:962-70. 10.1001\/jama.2021.1117","journal-title":"JAMA"},{"key":"ref4","unstructured":"Alexander MR. ( 2017). Accessed. October 05, 2022: https:\/\/emedicine.medscape.com\/article\/241381-treatment#d1."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"71","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al.. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018, 71:1269-324. 10.1161\/HYP.0000000000000066","journal-title":"Hypertension"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpx207","article-title":"The New ACC\/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"31","author":"Flack JM","year":"2018","unstructured":"Flack JM, Calhoun D, Schiffrin EL. The New ACC\/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults. Am J Hypertens. 2018, 31:133-5. 10.1093\/ajh\/hpx207","journal-title":"Am J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.18605","article-title":"The new 2017 ACC\/AHA guidelines \"up the pressure\" on diagnosis and treatment of hypertension","volume":"318","author":"Greenland P","year":"2017","unstructured":"Greenland P, Peterson E. The new 2017 ACC\/AHA guidelines \"up the pressure\" on diagnosis and treatment of hypertension. JAMA. 2017, 318:2083-4. 10.1001\/jama.2017.18605","journal-title":"JAMA"},{"key":"ref8","article-title":"New guidance on blood pressure management in low-risk adults with stage 1 hypertension","volume":"21","author":"Michael R Goetsch","year":"2021","unstructured":"Michael R Goetsch, Ethan Tumarkin, Roger S Blumenthal, et al.. New guidance on blood pressure management in low-risk adults with stage 1 hypertension. J Am Coll Cardiol. 2021, 21:20-1.","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-019-0980-5","article-title":"Comparison of the 2017 ACC\/AHA hypertension guideline with earlier guidelines on estimated reductions in cardiovascular disease","volume":"21","author":"Bundy JD","year":"2019","unstructured":"Bundy JD, Mills KT, He J. Comparison of the 2017 ACC\/AHA hypertension guideline with earlier guidelines on estimated reductions in cardiovascular disease. Curr Hypertens Rep. 2019, 21:76. 10.1007\/s11906-019-0980-5","journal-title":"Curr Hypertens Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright JT Jr","year":"2015","unstructured":"Wright JT Jr, Williamson JD, Whelton PK, et al.. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015, 373:2103-16. 10.1056\/NEJMoa1511939","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8776","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy CW","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013, 128:e240-327. 10.1161\/CIR.0b013e31829e8776","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-019-1251-4","article-title":"Evidence for and against ACC\/AHA 2017 guideline for target systolic blood pressure of < 130\u00a0mmHg in persons with type 2 diabetes","volume":"21","author":"Shen JI","year":"2019","unstructured":"Shen JI, Nicholas SB, Williams S, Norris KC. Evidence for and against ACC\/AHA 2017 guideline for target systolic blood pressure of &lt; 130\u00a0mmHg in persons with type 2 diabetes. Curr Cardiol Rep. 2019, 21:149. 10.1007\/s11886-019-1251-4","journal-title":"Curr Cardiol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000207","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"131","author":"Rosendorff C","year":"2015","unstructured":"Rosendorff C, Lackland DT, Allison M, et al.. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015, 131:e435-70. 10.1161\/CIR.0000000000000207","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-050416-024516","article-title":"Impact of the SPRINT trial on hypertension management","volume":"69","author":"Ghazi L","year":"2018","unstructured":"Ghazi L, Oparil S. Impact of the SPRINT trial on hypertension management. Annu Rev Med. 2018, 69:81-95. 10.1146\/annurev-med-050416-024516","journal-title":"Annu Rev Med"},{"key":"ref15","article-title":"1993 guidelines for the management of mild hypertension: memorandum from a WHO\/ISH meeting","volume":"71","year":"1993","unstructured":"1993 guidelines for the management of mild hypertension. memorandum from a WHO\/ISH meeting. Bull World Health Organ. 1993, 71:503-17.","journal-title":"Bull World Health Organ"},{"key":"ref16","article-title":"1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee","volume":"17","year":"1999","unstructured":"1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens. 1999, 17.151-83.","journal-title":"J Hypertens"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(94)90200-3","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society, and European Society of Hypertension.","volume":"15","author":"Py\u00f6r\u00e4l\u00e4 K","year":"1994","unstructured":"Py\u00f6r\u00e4l\u00e4 K, De Backer G, Graham I, et al.. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society, and European Society of Hypertension. . EurHeart J. 1994, 15:1300-31. 10.1016\/0021-9150(94)90200-3","journal-title":"EurHeart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816100-00003","article-title":"Prevention of coronary heart disease in clinical practice. Summary of recommendations of the second Joint Task Force of European and other societies on coronary prevention","volume":"16","author":"Wood D","year":"1998","unstructured":"Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Py\u00f6r\u00e4l\u00e4 K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the second Joint Task Force of European and other societies on coronary prevention. J Hypertens. 1998, 16:1407-14. 10.1097\/00004872-199816100-00003","journal-title":"J Hypertens"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90944-z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: an overview of randomized drug trials in their epidemiological context","volume":"335","author":"Collins R","year":"1990","unstructured":"Collins R, Peto R, MacMahon S, et al.. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: an overview of randomized drug trials in their epidemiological context. Lancet. 1990, 335:827-39. 10.1016\/0140-6736(90)90944-z","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington S","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360:1903-13. 10.1016\/s0140-6736(02)11911-8","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension","volume":"21","year":"2003","unstructured":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003, 21.1011-53. 10.1097\/00004872-200306000-00001","journal-title":"J Hypertens"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.83.1.356","article-title":"An updated coronary risk profile. A statement for health professionals","volume":"83","author":"Anderson KM","year":"1991","unstructured":"Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991, 83:356-62. 10.1161\/01.cir.83.1.356","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension","volume":"25","author":"Mancia G","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, et al.. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007, 25:1751-62. 10.1097\/HJH.0b013e3282f0580f","journal-title":"J Hypertens"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32832aa6b5","article-title":"When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal","volume":"27","author":"Zanchetti A","year":"2009","unstructured":"Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens. 2009, 27:923-34. 10.1097\/HJH.0b013e32832aa6b5","journal-title":"J Hypertens"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The felodipine event reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu L","year":"2005","unstructured":"Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A. The felodipine event reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens. 2005, 23:2157-72. 10.1097\/01.hjh.0000194120.42722.ac","journal-title":"J Hypertens"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr039","article-title":"Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial","volume":"32","author":"Zhang Y","year":"2011","unstructured":"Zhang Y, Zhang X, Liu L, Zanchetti A. Is a systolic blood pressure target &lt;140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. Eur Heart J. 2011, 32:1500-8. 10.1093\/eurheartj\/ehr039","journal-title":"Eur Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al.. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018, 39:3021-104. 10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"ref28","unstructured":"Hypertension. Screening, 1996. (1996). Accessed: November 02, 2022: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/hypertension-screening-1996#full%20recommendation...."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0749-3797(03)00121-1","article-title":"Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force","volume":"25","author":"Sheridan S","year":"2003","unstructured":"Sheridan S, Pignone M, Donahue K. Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med. 2003, 25:151-8. 10.1016\/s0749-3797(03)00121-1","journal-title":"Am J Prev Med"},{"key":"ref30","unstructured":"Evidence for the Reaffirmation of the U.S. Preventive Services Task Force Recommendation on Screening for High Blood Pressure. (2007). Accessed. November 01, 2022: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK33934\/."},{"key":"ref31","unstructured":"High Blood Pressure in Adults. Screening. (2015). Accessed: October 17, 2022: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/high-blood-pressure-in-adults-screening-monitorin...."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2981","article-title":"Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view","volume":"160","author":"Wright JT Jr","year":"2014","unstructured":"Wright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Dennison Himmelfarb CR. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014, 160:499-503. 10.7326\/M13-2981","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21669","article-title":"Screening for hypertension in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Guirguis-Blake JM","year":"2021","unstructured":"Guirguis-Blake JM, Evans CV, Webber EM, Coppola EL, Perdue LA, Weyrich MS. Screening for hypertension in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021, 325:1657-69. 10.1001\/jama.2020.21669","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7599.2002.tb00119.x","article-title":"National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"14","author":"Goolsby MJ","year":"2002","unstructured":"Goolsby MJ. National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification. J Am Acad Nurse Pract. 2002, 14:238-42. 10.1111\/j.1745-7599.2002.tb00119.x","journal-title":"J Am Acad Nurse Pract"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.003","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","year":"2004","unstructured":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis\r\n. 2004, 43.290. 10.1053\/j.ajkd.2004.03.003","journal-title":"Am J Kidney Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.01.019","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","year":"2005","unstructured":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005, 45.1-53. 10.1053\/j.ajkd.2005.01.019","journal-title":"Am J Kidney Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.12.005","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease","volume":"49","year":"2007","unstructured":"KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007, 49.S12-154. 10.1053\/j.ajkd.2006.12.005","journal-title":"Am J Kidney Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker LA","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, et al.. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014, 63:713-35. 10.1053\/j.ajkd.2014.01.416","journal-title":"Am J Kidney Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S010","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes-2021","volume":"44","year":"2021","unstructured":"10. Cardiovascular disease and risk management. standards of medical care in diabetes-2021. Diabetes Care. 2021, 44:S125-50. 10.2337\/dc21-S010","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S011","article-title":"11. Microvascular complications and foot care: standards of medical care in diabetes-2021","volume":"44","year":"2021","unstructured":"11. Microvascular complications and foot care. standards of medical care in diabetes-2021. Diabetes Care. 2021, 44:S151-67. 10.2337\/dc21-S011","journal-title":"Diabetes Care"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021","volume":"44","year":"2021","unstructured":"9. Pharmacologic approaches to glycemic treatment. standards of medical care in diabetes-2021. Diabetes Care. 2021, 44:S111-24. 10.2337\/dc21-S009","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120980-the-evolution-of-hypertension-guidelines-over-the-last-20-years-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:38Z","timestamp":1707507698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120980-the-evolution-of-hypertension-guidelines-over-the-last-20-years-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,13]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.31437","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,13]]}}}